weight loss drug prescriptions semaglutide tirzepatide q3 2024 data vs Semaglutide: Which is more effective in the real world? Real‐world titration, persistence & weight

Given the increasing emphasis on the use of GLP-1 RAs in clinical practice, it is important that all members of the healthcare team, including pharmacy professionals, understand current recommendations and patient-specific considerations for use

L.BennettC.GrndahlM

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice (SURE CANADA)

Mounjaro (Tirzepatide) , held by Eli-Lilly, initially registered for Type 2 Diabetes in December 2024, was granted approval for medical weight loss by SAHPRA in October 2025

Meta-analysis and observational studies have shown that Indian patients respond to GLP-1 RAs similarly to populations globally 2 , 3